Prevention of cardiac surgery-associated AKI by implementing the KDIGO guidelines in high risk patients identified by biomarkers: the PrevAKI randomized controlled trial.
Melanie MeerschChristoph SchmidtAndreas HoffmeierHugo Van AkenCarola WempeJoachim GerssAlexander ZarbockPublished in: Intensive care medicine (2017)
An implementation of the KDIGO guidelines compared with standard care reduced the frequency and severity of AKI after cardiac surgery in high risk patients. Adequately powered multicenter trials are warranted to examine mortality and long-term renal outcomes.
Keyphrases
- randomized controlled trial
- end stage renal disease
- cardiac surgery
- acute kidney injury
- ejection fraction
- newly diagnosed
- healthcare
- quality improvement
- primary care
- peritoneal dialysis
- clinical trial
- palliative care
- risk factors
- systematic review
- skeletal muscle
- patient reported outcomes
- adipose tissue
- cardiovascular events
- insulin resistance
- chronic pain